Welcome, Guest. Please login or register.
December 26, 2024, 09:10:50 am

Login with username, password and session length


Members
  • Total Members: 6315
  • Latest: DRG
Stats
  • Total Posts: 55137
  • Total Topics: 4855
  • Online Today: 650
  • Online Ever: 3061
  • (September 25, 2024, 11:40:40 pm)
Users Online
Users: 1
Guests: 255
Total: 256

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: What To Look Out For if You're On Viekira Pak or Technivie  (Read 6308 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
What To Look Out For if You're On Viekira Pak or Technivie
« on: October 26, 2015, 01:42:34 pm »
The U.S. Food and Drug Administration (FDA) is now requiring AbbVie to change the labels for its two latest hepatitis C virus treatments, after at least 26 people reported serious liver injury while taking the medications.

In most of these cases, the liver damage occurred within the first 1 to 4 weeks of treatment. Though these instances of injury were rare, here's what to look out for:

Fatigue, weakness, loss of appetite, nausea and vomiting, yellow eyes or skin (jaundice), or light-colored stools, which may indicate liver injury.

The health agency cautions individuals taking the therapies not to discontinue their use without first discussing the matter with a health professional.

For more info: http://www.hepmag.com/articles/AbbVie_warning_2501_27940.shtml


 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.